Varicella zoster virus meningo-encephalo-myelitis in an immunocompetent patient

Neurol Sci. 2008 Sep;29(4):279-83. doi: 10.1007/s10072-008-0982-6. Epub 2008 Sep 20.

Abstract

Objective: To describe clinical, MRI and cerebrospinal fluid (CSF) features of a varicella zoster virus (VZV) related meningo-encephalo-myelitis (MEM) without rash in an immunocompetent female.

Patient: An 85 year old immunocompetent woman with mild hyperthermia and acute, severe MEM.

Intervention: Serum antibodies and CSF PCR were searched for several viruses. Brain and spinal cord MRI were performed. Immunological profile.

Treatments: i.v. acyclovir 30 mg/kg/day; i.v. 6-MP 125 mg/day.

Results: Marked CSF lymphomonocytic pleocytosis, blood-brainbarrier damage, and PCR detection of 3.05 X 10 6 copies of VZV DNA. MRI revealed lesions of the meninges, brain and spinal cord. No evidence of immunosuppression.

Conclusion: We highlight the importance of considering the possibility of VZV related MEM, even in immunocompetent patients. We also provide a MRI description of VZV related multifocal myelitis, not previously available. As supported by other reports, we underline the necessity of a prompt therapeutic intervention in this life-threatening condition.

Publication types

  • Case Reports

MeSH terms

  • Acyclovir / therapeutic use
  • Aged, 80 and over
  • Antiviral Agents / therapeutic use
  • Blood-Brain Barrier / immunology
  • Blood-Brain Barrier / pathology
  • Blood-Brain Barrier / virology
  • Brain / immunology
  • Brain / pathology
  • Brain / virology
  • Cerebrospinal Fluid / cytology
  • Early Diagnosis
  • Encephalitis, Varicella Zoster / drug therapy
  • Encephalitis, Varicella Zoster / immunology
  • Encephalitis, Varicella Zoster / physiopathology*
  • Fatal Outcome
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Meningitis, Viral / immunology
  • Meningitis, Viral / physiopathology*
  • Meningitis, Viral / virology
  • Spinal Cord / immunology
  • Spinal Cord / pathology
  • Spinal Cord / virology
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Acyclovir